发明名称 NOVEL ADAMTS-13 MUTANT
摘要 An enhanced disintegrin-like domain, and metalloprotease, with an isolated human thrombospondin type 1 motif, member 13 (ADAMTS-13) that includes substitutions at one or more positions in the isolated human ADAMTS-13.
申请公布号 US2015050716(A1) 申请公布日期 2015.02.19
申请号 US201414527856 申请日期 2014.10.30
申请人 THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE 发明人 SOEJIMA Kenji
分类号 C12N9/64;A61K38/48 主分类号 C12N9/64
代理机构 代理人
主权项 1. A method of reducing a reactivity of ADAMTS-13 to an anti-ADAMTS-13 neutralizing antibody, comprising substituting at least one charged amino acid in a disintegrin-like domain, a cysteine-rich domain or a spacer domain of ADAMTS-13 other than the following amino acids with a different amino acid: arginine at position 326, aspartic acid at position 330, aspartic acid at position 343 and arginine at position 349 in the disintegrin-like domain, aspartic acid at position 480, arginine at position 488, arginine at position 498, arginine at position 507, aspartic acid at position 533 and aspartic acid at position 543 in the cysteine-rich domain, and glutamic acid at position 641 and arginine at position 660 in the spacer domain.
地址 Kumamoto-shi JP